In the present study, we investigated posttranslational regulatory mechanisms downstream of the IL-6/STAT3/FRA1 inflammatory signaling axis that mediate colon cancer stemness and malignancy and explored novel combinatorial therapeutic approaches to target CRC stem and bulk cells. The gene discussed is IL6; the disease is colorectal carcinoma.